Emc Capital Management Pfizer Inc Transaction History

Emc Capital Management

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $608,694 - $704,245	16,852 Added 1573.48%	17,923 $18,000
Q1 2023 May 22, 2023	BUY	$39.39 - $51.28 $433 - $564	11 Added 1.04%	1,071 $44,000
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $334 - $436	8 Added 0.76%	1,060 $54,000
Q3 2022 Nov 15, 2022	BUY	$43.76 - $53.42 $393 - $480	9 Added 0.86%	1,052 $52,000
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $418 - $496	9 Added 0.87%	1,043 $55,000
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $366 - $453	8 Added 0.78%	1,034 $54,000
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $330 - $490	8 Added 0.79%	1,026 $61,000
Q3 2021 Nov 02, 2021	BUY	$39.25 - $50.42 $314 - $403	8 Added 0.79%	1,018 $45,000
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $35 - $40	1 Added 0.1%	1,010 $46,000
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $323 - $366	9 Added 0.9%	1,009 $46,000
Q4 2020 Feb 24, 2021	BUY	$33.47 - $42.56 $33,470 - $42,560	1,000 New	1,000 $37,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Emc Capital Management, based on Form 13F filings with the SEC.

Stay updated on Emc Capital Management with notifications on news.